¼¼°èÀÇ mRNA ÀÇ¾à ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)
Global mRNA Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
»óǰÄÚµå : 1489179
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 170 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

mRNA ÀÇ¾à ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 122¾ï 3,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 498¾ï 2,000¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2024-2032³â CAGRÀº 16.89%ÀÔ´Ï´Ù.

mRNA ÀǾàÀº ¸Þ½ÅÀú RNA(mRNA) ºÐÀÚ¸¦ ÀÌ¿ëÇØ ¼¼Æ÷°¡ Ä¡·á¿ë ´Ü¹éÁúÀ̳ª Ç׿øÀ» »ý»êÇϵµ·Ï Áö½ÃÇÏ´Â ¾à¹°ÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ mRNA ±â¹Ý ¾à¹°Àº ½ÅüÀÇ ÀÚ¿¬ÀûÀÎ ´Ü¹éÁú ÇÕ¼º ¸ÞÄ¿´ÏÁòÀ» ÀÌ¿ëÇÏ¿© ƯÁ¤ Ä¡·á¿ë ºÐÀÚ¸¦ »ý»êÇÔÀ¸·Î½á Áúº´À» Ä¡·áÇÏ´Â »õ·Î¿î Á¢±Ù¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ¾à¹°µéÀº ¹é½Å, ¾Ï ¸é¿ªÄ¡·á, ´Ü¹éÁú ´ëü¿ä¹ý, Àç»ýÀÇ·á µî ´Ù¾çÇÑ ºÐ¾ß¿¡ Àû¿ëµÉ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

mRNA ±â¹Ý ÀǾàǰ °³¹ß¿¡ ´ëÇÑ °ü½É°ú ÅõÀÚ°¡ Áõ°¡Çϸ鼭 mRNA ÀÇ¾à ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. mRNA ÀǾàÀº ü³» ÀÚ¿¬ ´Ü¹éÁú ÇÕ¼º ¸ÞÄ¿´ÏÁòÀ» ÀÌ¿ëÇÏ¿© ¼¼Æ÷ ³»¿¡¼­ Ä¡·á¿ë ´Ü¹éÁú°ú Ç׿øÀ» »ý»êÇÏ¿© Ç¥ÀûÈ­µÈ ¸ÂÃãÇü Ä¡·á Àü·«À» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ÀǾàǰ °³¹ß¿¡ ´ëÇÑ »õ·Î¿î Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù. ÀǾàǰ °³¹ß¿¡ »õ·Î¿î Á¢±Ù¹ýÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ mRNA Àü´Þ ½Ã½ºÅÛ, ÁöÁú ³ª³ëÀÔÀÚ Á¦Á¦, mRNA ¾ÈÁ¤È­ ±â¼úÀÇ ¹ßÀüÀº Ä¡·á È¿°ú, »ýü ÀÌ¿ë·ü, ¾ÈÀü¼º ÇÁ·ÎÆÄÀÏÀ» Çâ»ó½ÃÄÑ ½ÃÀå Ãâ½Ã¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ mRNA ±â¹Ý COVID-19 ¹é½ÅÀÇ ½Å¼ÓÇÑ °³¹ß°ú ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀº ¹é½Å °³¹ß¿¡¼­ mRNA ±â¼úÀÇ ½ÇÇö °¡´É¼º°ú È®À强À» ÀÔÁõÇϰí, ´Ù¸¥ Áúº´¿¡ ´ëÇÑ mRNA ÀǾ࿡ ´ëÇÑ ÅõÀÚ¿Í ¿¬±¸¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦¾à»ç, »ý¸í°øÇÐ ±â¾÷, Çмú¿¬±¸ ±â°ü, Á¤ºÎ ±â°üÀÇ Çù·ÂÀº mRNA ½Å¾à °³¹ßÀÇ Çõ½Å°ú ÆÄÀÌÇÁ¶óÀÎ °³¹ßÀ» ÃËÁøÇÏ°í ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ±ÔÁ¦ À庮, Á¦Á¶ÀÇ º¹À⼺, À¯ÀüÀÚ Ä¡·á¿¡ ´ëÇÑ »çȸÀû ÀνĿ¡ ´ëÇÑ ¿ì·Á´Â ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç ¸®Æ÷Æ®´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇϰí, ¼¼°è ·¹º§¿¡¼­ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ ÅøÀº ¼¼°èÀÇ mRNA ÀÇ¾à ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. mRNA ÀÇ¾à ¾÷°èÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

mRNA ÀÇ¾à ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ·¹º§ ºÎ¹®¿¡ °üÇÑ »ó¼¼ µ¥ÀÌÅ͸¦ Á¦°øÇϰí, ÀÌ¿¡ µû¶ó Àü·«°¡°¡ ÇâÈÄ ±âȸ¿Í ÇÔ²² °¢°¢ÀÇ Á¦Ç° ¹× ¼­ºñ½ºÀÇ Å¸±êÃþÀ» ½Äº°Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.

¿ëµµº°

À¯Çüº°

ÃÖÁ¾ ¿ëµµº°

Áö¿ªº° ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ & ¾ÆÇÁ¸®Ä«¿¡¼­ mRNA ÀÇ¾à ½ÃÀåÀÇ ÇöÀç ¹× ÇâÈÄ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯¸í Àü Áö¿ª¿¡ °Ç³Ê°¡´Â °³º° ¿ëµµ ºÎ¹®ÀÇ ¼ö¿ä¡¤ÃßÁ¤¡¤¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. Value Market ResearchÀÇ Á¶»çÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü ¸®Æ÷Æ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå mRNA ÀǾà - »ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ mRNA ÀÇ¾à ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦6Àå ¼¼°èÀÇ mRNA ÀÇ¾à ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ¼¼°èÀÇ mRNA ÀÇ¾à ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ mRNA ÀÇ¾à ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå mRNA ÀÇ¾à ±â¾÷ÀÇ °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global demand for mRNA Therapeutics Market is presumed to reach the market size of nearly USD 49.82 Billion by 2032 from USD 12.23 Billion in 2023 with a CAGR of 16.89% under the study period 2024-2032.

mRNA therapeutics is a class of drugs that utilize messenger RNA (mRNA) molecules to instruct cells to produce therapeutic proteins or antigens within the body. These mRNA-based drugs offer a novel approach to treating diseases by harnessing the body's natural protein synthesis machinery to produce specific therapeutic molecules. These drugs hold promise for a wide range of applications, including vaccines, cancer immunotherapy, protein replacement therapy, and regenerative medicine.

MARKET DYNAMICS

The growing interest and investment in mRNA-based drug development drives the market for mRNA therapeutics. The versatility and potential of mRNA technology to address unmet medical needs, including infectious diseases, cancer, genetic disorders, and rare diseases, fuel market growth. mRNA therapeutics offer a novel approach to drug development by harnessing the body's natural protein synthesis machinery to produce therapeutic proteins or antigens within cells, enabling targeted and customizable treatment strategies. Moreover, advancements in mRNA delivery systems, lipid nanoparticle formulations, and mRNA stabilization techniques enhance therapeutic efficacy, bioavailability, and safety profiles, driving market adoption.

Additionally, the rapid development and regulatory approval of mRNA-based COVID-19 vaccines demonstrate the feasibility and scalability of mRNA technology for vaccine development, accelerating investment and research in mRNA therapeutics for other diseases. Furthermore, collaborations between pharmaceutical companies, biotechnology firms, academic research institutions, and government agencies propel innovation & pipeline development in mRNA drug discovery, further stimulating market growth. However, regulatory hurdles, manufacturing complexities, and public perception concerns regarding genetic therapies may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mRNA Therapeutics. The growth and trends of mRNA Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the mRNA Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

By Type

By End-use

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the mRNA Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mRNA Therapeutics market include Moderna Inc., BioNTech SE, CureVac N.V., Arcturus Therapeutics, Sanofi, GSK Plc., Argos Therapeutics Inc., Ethris, Pfizer Inc., AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. MRNA THERAPEUTICS - INDUSTRY ANALYSIS

4. VALUE CHAIN ANALYSIS

5. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY APPLICATION

6. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY TYPE

7. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY END-USE

8. GLOBAL MRNA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

9. COMPETITIVE LANDSCAPE OF THE MRNA THERAPEUTICS COMPANIES

10. COMPANY PROFILES OF MRNA THERAPEUTICS INDUSTRY

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â